Literature DB >> 15364944

Arginine methylation of scaffold attachment factor A by heterogeneous nuclear ribonucleoprotein particle-associated PRMT1.

Frank Herrmann1, Maike Bossert, Andrea Schwander, Ercan Akgün, Frank O Fackelmayer.   

Abstract

Components of the heterogeneous nuclear ribonucleoprotein (hnRNP) complex and other nucleic acid-binding proteins are subject to methylation on specific arginine residues by the catalytic activity of arginine methyltransferases. The methylation has been implicated in transcriptional regulation and RNA and protein trafficking and signal transduction, but the mechanism by which these functions are achieved has remained undetermined. We show here that the predominant arginine methyltransferase in human cells, protein arginine methyltransferase 1 (PRMT1), is associated with hnRNP complexes, dependent on the methylation status of the cell, and that it methylates its preferred substrates in situ. Binding of PRMT1 occurs through physical interaction with scaffold attachment factor A (SAF-A), also known as hnRNP-U, which is quantitatively methylated by PRMT1 in all investigated cell lines as determined by a novel, highly specific, methylation-sensitive antibody.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364944     DOI: 10.1074/jbc.M407332200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  Small Molecule Inhibitors of Protein Arginine Methyltransferases.

Authors:  Hao Hu; Kun Qian; Meng-Chiao Ho; Y George Zheng
Journal:  Expert Opin Investig Drugs       Date:  2016-02-16       Impact factor: 6.206

2.  PRMT1-p53 Pathway Controls Epicardial EMT and Invasion.

Authors:  Olan Jackson-Weaver; Nicha Ungvijanpunya; Yuan Yuan; Jiang Qian; Yongchao Gou; Jian Wu; Hua Shen; Yibu Chen; Meng Li; Stéphane Richard; Yang Chai; Henry M Sucov; Jian Xu
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

3.  Clinical evaluation of PRMT1 gene expression in breast cancer.

Authors:  Konstantina Mathioudaki; Andreas Scorilas; Alexandros Ardavanis; Peggy Lymberi; Evangelos Tsiambas; Marina Devetzi; Aikaterini Apostolaki; Maroulio Talieri
Journal:  Tumour Biol       Date:  2011-01-13

4.  PELP1 oncogenic functions involve alternative splicing via PRMT6.

Authors:  Monica Mann; Yi Zou; Yidong Chen; Darrell Brann; Ratna Vadlamudi
Journal:  Mol Oncol       Date:  2013-12-30       Impact factor: 6.603

5.  Control of the DNA methylation system component MBD2 by protein arginine methylation.

Authors:  Choon Ping Tan; Sara Nakielny
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

6.  RioK1, a new interactor of protein arginine methyltransferase 5 (PRMT5), competes with pICln for binding and modulates PRMT5 complex composition and substrate specificity.

Authors:  Gernot Guderian; Christoph Peter; Julia Wiesner; Albert Sickmann; Klaus Schulze-Osthoff; Utz Fischer; Matthias Grimmler
Journal:  J Biol Chem       Date:  2010-11-16       Impact factor: 5.157

Review 7.  X chromosome inactivation and autoimmunity.

Authors:  Wesley H Brooks
Journal:  Clin Rev Allergy Immunol       Date:  2010-08       Impact factor: 8.667

8.  Inhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells.

Authors:  Arindam Dasgupta; Kyung-Jin Jung; Soo-Jin Jeong; John N Brady
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

Review 9.  Finishing touches: post-translational modification of protein factors involved in mammalian pre-mRNA 3' end formation.

Authors:  Kevin Ryan; David L V Bauer
Journal:  Int J Biochem Cell Biol       Date:  2008-04-01       Impact factor: 5.085

10.  Protein arginine methyltransferase 6 regulates multiple aspects of gene expression.

Authors:  Matthew J Harrison; Yue Hang Tang; Dennis H Dowhan
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.